Charles is with the Burnet Institute and Monash, employed as a engagement coordinator working on community initiatives connecting to research in hepatitis C. Also undertaking postgraduate research on user experiences on injectable buprenorphine. Always connects a living experience viewpoint regardless of role. Remains committed to the well-being of his community.

Dr Francis Lukuwi Benedict is a Psychiatrist working at Temeke Regional Referral Hospital as the head of department of Psychiatry and addiction services. He is supervising the daily managements of around 1000 PWUD clients attending at Temeke Regional referral Hospital, Dar es Salaam, Tanzania

Human Rights and Key Populations Programme Manager for NACOSA, the Principal Recipient for the South African Global Fund programme. Qualifications: BSocSc; Honours and a Master Degree in Social Policy and Management (University of Cape Town); and a Masters in International Social and Health Policy (University College of Oslo, Norway).

Tshireletso Ngobeni is a Clinical Associate with a Master’s in Public Health (Disease Control) and extensive experience in community-oriented substance use programs. She currently works with the Community Oriented Substance Use Programme (COSUP) in Tshwane, focusing on harm reduction, treatment access, and community-based care. Her research interests include homelessness, substance use, and public health interventions. Tshireletso is also a published author in the South African Medical Journal, where her work explores homelessness in the context of substance use.

Professor Dietze is one of Australia's leading alcohol and other drug researchers. He leads large studies of people who use drugs and has played a major role in the development of responses to opioid overdose in particular.

Dr Elaine Saayman is a clinician and researcher at Sediba Hope Medical Centre NPC, in Tshwane, South Africa, with a passion for improving access to healthcare for underserved populations. Her experience spans across various aspects of HIV and viral hepatitis management, including clinical care, research, and program implementation.

Dr Blaire Brewerton is a newly Fellowed Addiction Medicine Specialist, having trained as a Specialist Physician in Adelaide, South Australia. He is passionate about delivery of specialist care to underprivileged and under resourced areas. He has a strong interest in the interface and medical sequelae of addiction.

Matthew is an International Board member with INHSU, social media editor with IJDP, drug culture advisor with ChangeMark, and a harm reduction knowledge broker. He was also on the 64th Canadian delegation to the Commission on Narcotic Drugs. He is a current drug user and a formerly incarcerated person.

Juls Budau is a research advisor at the School of Population and Public Health at the University of British Columbia, and an MSW student at the University of Northern British Columbia. She is also an OAT/PSS patient with eight years of frontline harm reduction experience.